Home > Financial Ratios > IPCA LABORATORIES

IPCA LABORATORIES
Core EBITDA Growth

    Back to All Ratios
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

IPCA LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 25.7837.28-23.51-14.3564.84

What is the latest Core EBITDA Growth ratio of IPCA LABORATORIES ?

The latest Core EBITDA Growth ratio of IPCA LABORATORIES is 25.78 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202525.78
Mar202437.28
Mar2023-23.51
Mar2022-14.35
Mar202164.84

How is Core EBITDA Growth of IPCA LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 25.78
-30.85
Mar2024 37.28
Positive
Mar2023 -23.51
Negative
Mar2022 -14.35
Negative
Mar2021 64.84 -

Other Financial Ratios of IPCA LABORATORIES


Compare Core EBITDA Growth ratio of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹39,216.9 Cr -1.1% 2.8% 19% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,528.0 Cr -2.5% 4.7% 7.1% Stock Analytics
DIVIS LABORATORIES ₹158,686.0 Cr -2.1% -0.2% 7.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,457.0 Cr -3.4% 0.7% 39.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,339.0 Cr -1.9% 2% 16.1% Stock Analytics
CIPLA ₹100,056.0 Cr -4.3% -6.5% -11.9% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

-1.1%

2.8%

19%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses